Status:
COMPLETED
Clinical Survey on the Stroke Prevention in Atrial Fibrillation in Asia
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Asia Pacific Heart Rhythm Society (APHRS)
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
Despite relatively lower prevalence of atrial fibrillation (AF) in Asians (\~1%) than Caucasians (\~2%) as reported in observational studies, Asia has a much higher overall disease burden, due to its ...
Detailed Description
This is a prospective observational study on the current practice of stroke prevention for AF in Asia. We propose to recruit 5,000 patients (\~1000 patients per country) from 5 countries in Asia-Pacif...
Eligibility Criteria
Inclusion
- Patients will be officially enrolled in the study only if ECG diagnosis of AF has been made.
- The qualifying episode of AF should have occurred within one year before the date of baseline.
- AF is the primary or secondary diagnosis, i.e. the current admission / visit may be due to other reasons.
- Patients need not be in AF at the time of enrolment.
- Signed Patient Inform Consent if applicable
Exclusion
- No ECG/Holter with AF recorded.
- Only atrial flutter recorded.
- The qualifying episode of AF occurred more than one year before the date of baseline.
- Age \<18 years.
Key Trial Info
Start Date :
April 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2021
Estimated Enrollment :
4504 Patients enrolled
Trial Details
Trial ID
NCT04807049
Start Date
April 1 2016
End Date
March 1 2021
Last Update
March 19 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, China
2
National Heart Centre Singapore
Singapore, Singapore